SNMMI image of the year: PSMA PET imaging of theranostic for advanced prostate cancer
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to radionuclide therapy targeting prostate specific membrane antigen (PSMA) with the radionuclide lutetium-177 ...
Jun 27, 2018
0
2